NEW YORK, Nov. 18, 2010 /PRNewswire-USNewswire/ -- AMDeC, the Academy for Medical Development and Collaboration, announced today that Agilent Technologies has renewed and expanded its agreement to offer AMDeC member institutions advanced technology access and discounted pricing on a number of products important for genomics and proteomics research. AMDeC is a consortium of 22 pre-eminent academic medical research institutions in the New York region. Agilent is a leading global provider of instrumentation, supplies, software and services to the life science and chemical analysis markets.
The long-standing relationship between the two organizations is now enhanced with Agilent's listing on AMDeC F.I.R.S.T.™ (Facilities Instrumentation Resources Services & Technologies), the first-ever comprehensive, real-time online registry and database of biomedical research technology and resources. This will facilitate AMDeC member access to substantial savings through product discounts across the spectrum of Agilent's genomics product lines, including microarray slides, bioreagents, hybridization consumables, and bioanalyzers.
"Creating ties like this between industry and academia benefits all parties. For our member institutions, this agreement will realize substantial savings, which is especially crucial in this time of constrained budgets," said Maria Mitchell, Ph.D., President of AMDeC. "For Agilent, this agreement provides greater access to and collaboration with the academic biomedical research community."
"Recognizing the critical role of genomics in advancing scientific research, we are especially pleased to be taking a lead
Copyright©2010 PR Newswire.
All rights reserved